제약회사분석,동아제약,한미약품,유한양행,제약회사재무분석,재무분석사례,재무비율분석,영문재무분석,영문재무분석사례
- 최초 등록일
- 2012.09.13
- 최종 저작일
- 2012.09
- 28페이지/
MS 파워포인트
- 가격 3,000원
소개글
제약회사분석,동아제약,한미약품,유한양행,제약회사재무분석,재무분석사례,재무비율분석,영문재무분석,영문재무분석사례
목차
1. Introduction
2. Companies` profile
(1) 동아제약
(2) 유한양행
(3) 한미약품
3. Financial Ratio
4. Stock Information
5. Conclusion
본문내용
Introduction
The type of drug market is becoming advanced
Expanding facilities to meet international standards
Ability to invest is needed
Profile
Dong-A
No.1 pharmaceutical company for 40years
Strong at biotechnology
박카스F, 판피린F, 써큐란, 암씨롱
Profile-DongA
History
Profile-DongA
Subsidiaries
Profile-DongA
Ownership composition
Profile-Yuhan
Yuhan
Founded in 1926
‘Only strong nation can regain their right’
‘The company’s profit must return to the society that raised the company’
Separation of capital and management
Profile-Yuhan
Profile-Yuhan
Subsidiaries
Ownership composition
Profile-Hanmi
Hanmi
Founded in 1973
‘We make better medicine for precious life’
Win the prize of 2010 Asian consumer prize hosted Asian Economic News
참고 자료
없음
